NR 3-4/2003

get MSIE 4.x or better from www.microsoft.com/ie

Objawy uboczne w trakcie leczenia Solu-Medrolem zapalenia nerwu wzrokowego w przebiegu SM

Side effects during treatment with Solu-Medrol optic neuritis in course of SM

Lidia Mazur-Chłodek, Aniela Kaliciak-Kempińska

Z Oddziału Okulistycznego Wojewódzkiego Szpitala Specjalistycznego nr 3 w Rybniku
Ordynator: lek. med. Helena Pater-Jajdelska

Summary: The aim of this research is, to show the action mechanism of metyloprednizolon and the side - effects of the Solu-Medrol application in the treatment of demyelinization neuritis of ophtalmic nerve in sclerosis multiplex. In research, there were described the side-effects after second Solu-Medrol bolus dose given to a 44-year-old patient. She has suffered from SM and demyelinization neuritis of ophtalmic nerve with rapid deterioration of visual acuity for 14 years. In the years 1995-2002 there has not been any case of side-effects similar to this patient's, among all the 30 other patients treated with Solu-Medrol. It confirms the usefulness of bolus dose metyloprednizolon therapy applied to patients suffering from ophtalmic nerve demyelinization with rapid deterioration of visual acuity.
Słowa kluczowe:  zapalenie nerwu wzrokowego, Solu-Medrol (sól sodowa bursztynianu metyloprednizolonu), demielinizacja.
Key words: optic neuritis, methyloprednisolone sodium succinate (metyloprednizolon), demyelinization.



linia-lewa.gif (150 bytes)


Wydawca dwumiesięcznika medycznego "Klinika Oczna"
Oftal Sp. z o.o.

ul. Lindleya4, 02-005 Warszawa
Oddział: 03-709 Warszawa ul. Sierakowskiego 13 (Szpital)

tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45

e-mail: ored@okulistyka.com.pl